Samuel Backenroth - 01 Jan 2023 Form 3 Insider Report for Vascular Biogenics Ltd.

Role
Chief Financial Officer
Signature
/s/ Samuel Backenroth
Issuer symbol
N/A
Transactions as of
01 Jan 2023
Net transactions value
$0
Form type
3
Filing time
03 Jan 2023, 20:04:06 UTC
Next filing
18 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VBLT Restricted Stock Units 01 Jan 2023 Ordinary Shares 700,000 Direct F1
holding VBLT Stock Option (Right to Buy) 01 Jan 2023 Ordinary Shares 307,500 $2.22 Direct F2
holding VBLT Stock Option (Right to Buy) 01 Jan 2023 Ordinary Shares 79,406 $2.31 Direct F3
holding VBLT Stock Option (Right to Buy) 01 Jan 2023 Ordinary Shares 52,937 $2.12 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") granted under the Issuer's Employee Share Ownership and Option Plan (2014) (the "2014 Plan"). Each RSU represents a contingent right to receive one Ordinary Share, par value NIS 0.01, with an exercise price of NIS 0.01, has no expiration date and vests as follows: 75% of the RSUs shall vest on March 31, 2023, with the remaining 25% vesting on August 9, 2024.
F2 These options were granted on 10/04/21 under the 2014 Plan and vest over four years commencing on the grant date such that 25% vest on the first anniversary of the date of grant and quarterly thereafter for three years such that they are vested in full on the four-year anniversary of the grant date.
F3 These options were granted on 12/07/21 under the 2014 Plan and vest over four years commencing on the grant date such that 25% vest on the first anniversary of the date of grant and quarterly thereafter for three years such that they are vested in full on the four-year anniversary of the grant date.
F4 These options were granted on 01/02/2022 under the 2014 Plan and vest over three years commencing on the grant date such that 1/3 vest on the first anniversary of the date of grant and then quarterly thereafter for two years, such that they are vested in full on the three-year anniversary of the grant date.

Remarks:

Exhibit 24 - Power of Attorney